Samsung Bioepis Humira biosimilar wins FDA approval

79

(This story corrects to show that Hadlima belongs to Samsung Bioepis not Merck & Co Inc, which is commercializing the drug in the United States)

http://feeds.reuters.com/~r/reuters/healthNews/~3/6TGv3vTsyjw/samsung-bioepis-humira-biosimilar-wins-fda-approval-idUSKCN1UI2S2